Font Size: a A A

Regulation Role Of Peripheral Dopamine System In Acute Pancreatitis

Posted on:2019-11-13Degree:DoctorType:Dissertation
Country:ChinaCandidate:X HanFull Text:PDF
GTID:1484305894958129Subject:Internal medicine
Abstract/Summary:PDF Full Text Request
Aims:This study focused on the role of dopamine(DA)signaling pathway in acute pancreatitis(AP)and its related mechanisms,to find new therapeutic strategies for AP.Methods:In vitro,CCK was used to stimulate pancreatic acinar cell(PAC),LPS and IFN-?to stimulate bone marrow-derived macrophage(M?);in vivo,cearulein or L-arginine-induced AP model was built in wild-type,pancreas(Pdx1+/creDrd2flox/flox,Drd2-/-)or myeloid-specific(Lys M+/creDrd2flox/flox,Drd2-/-)Drd2 knockout mice.Change of DA system and the influence of DRD agonist or antagonist on experimental AP was discussed.We used serum amylase,lipase and histological score to assess the severity of AP;western blot to detect Akt-NF?B,NADPH oxidase mediated ROS generation and NLRP3 inflammasome pathways;EMSA to measure NF?B activity;Transwell to investigate M?and neutrophil migration;flow cytometry and q RT-PCR to detect M?status and function change,the levels of inflammatory cytokines and chemokines,etc.Results:The DA synthetic and metabolic system of PAC were activated but DRD was significantly down-regulated in AP;DRD2 antagonist can block the function of DA in inhibiting the activation of I?B?-NF?B and expression of TNF-?,IL-1?,IL-6 in AP,but DRD1 antagonist cannot;pancreatic specific Drd2-/-significantly aggravates the pancreatic and lung injury,immune cell infiltration,Akt-NF?B pathway,and TNF-?,IL-1?,IL-6,CCL2,CXCL2 levels in AP;inhibitory effect of DRD2 agonist(Quinpirole)on Akt-NF?B pathway and the inflammatory cytokines in AP was blocked by PP2A antagonist(OA);DRD2 inhibited the levels of CCL2and CXCL2 in PAC by inhibiting Akt-NF?B pathway via PP2A,and inhibited the migration of M?and neutrophils.The DA system is activated both in M1 and M2-type M?,but DRD decreased in M1 and increased in M2;M?in AP exhibited M1 subtype;DRD2 activation can inhibit the M1-type M?and promote M2 in the pancreas;myeloid-specific Drd2-/-increased the number of M1-type M?in pancreatic tissue and aggravated AP;Quinpirole didn't inhibit M1-type M?from Drd2-/-mice;Quinpirole can significantly reduce the p47phox translocation to membrane and ROS+cell number in M1-type M?,inhibit the NF?B and NLRP3 signaling pathway in a dose-dependent manner;the activation of NADPH oxidase,NF?B and NLRP3 pathways in Drd2-/-M1-type M?was significantly increased compared to the wild-type group;Quinpirole can significantly inhibit these phenomena in M1-type M?of wild type group,but has no significant effect on Drd2-/-group.Conclusions:In PAC,DRD2 ameliorated inflammatory response by inhibiting Akt-NF?B signaling pathway via PP2A during AP.In M?,DRD2 inhibited NADPH oxidase-dependent NF?B and NLRP3inflammasome pathways to inhibit M1-type M?and promote M2.This study comprehensively elucidated the specific mechanisms of DRD2signaling pathway to reduce AP inflammatory response from two perspectives of PAC and M?.
Keywords/Search Tags:Acute pancreatits, dopamine D2 receptor, macrophage, PP2A, NADPH oxidase
PDF Full Text Request
Related items